Ohh boy .... thank you for your service . So why didn't they apply to FDA. LG said on phone in no uncertain terms that applicantion to FDA will be alongside MHRA.
Look! Gary was correct! Dr. Linda Liau said “…it is feasible to have this vaccine manufactured at 94 centers.” Point of service language! Sorry biosectinvestor but this point goes to Gary. Now how do you do this without increasing very expensive Class B clean room space? Hmmm. Manufacturing, manufacturing, manufacturing. Class C clean room space being built out now. Gee, what could that be for?; ). Best wishes.
You should’ve dated these transcripts. Since T cell therapy has shown improvement in GBM. And with the confusion on pseudo progression we don’t know how many non progression patients actually moved into the L arm, and why the control depleted?
This one always bother me. I agree, it is surprising…and worrisome, imo.
>>Dr. Liau: Surprisingly, no. We actually—there was actually very good tolerability for the vaccine and the safety profile was exceptionally benign.
LOL, no one is interested in your free service! They would have lost more than 70% if they listened to you 3 years ago.
We are looking forward to yet another of your post in 2026 bragging about averaging down and how you beat the market to it, LOL! ;) LP won’t disappoint!